Novo Nordisk A S reported net income of $48.55B for the quarter ended Dec 2019. This income statement covers 29 quarters of results from Mar 2012 through Dec 2019, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2012 | Jun2012 | Sep2012 | Dec2012 | Mar2013 | Jun2013 | Sep2013 | Dec2013 | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Dec2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 4.80B | ||||||||||||||||||||||||||||
| Revenue & cost | |||||||||||||||||||||||||||||
| Revenue | 3.98B | 3.96B | 88.81B | 3.81B | 4.00B | 3.99B | 107.93B | 4.02B | 4.17B | 4.13B | 4.29B | 4.07B | 4.23B | 4.20B | 4.42B | 4.45B | 4.38B | 4.33B | 4.55B | ||||||||||
| Gross Profit | 3.30B | 3.35B | 3.47B | 3.22B | 3.43B | 3.42B | 3.56B | 3.39B | 3.55B | 3.53B | 3.58B | 3.46B | 3.58B | 3.53B | 3.68B | 3.75B | 3.69B | 3.64B | 101.93B | ||||||||||
| Operating items | |||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.57B | 0.65B | 0.65B | 0.49B | 0.45B | 0.49B | 0.49B | 0.51B | 0.52B | 0.47B | 0.50B | 0.52B | 0.62B | 0.55B | 0.53B | 0.57B | 14.22B | ||||||||||||
| Other Operating ExpensesOther Opex | 0.04B | 0.03B | 0.03B | 0.42B | 0.05B | 0.03B | 1.11B | 0.04B | 0.02B | 0.03B | 0.04B | 0.03B | 0.07B | 0.03B | 0.06B | 0.06B | 0.03B | 0.60B | |||||||||||
| Operating ExpensesOpex | 0.57B | 0.65B | 0.65B | 0.49B | 0.45B | 0.49B | 0.49B | 0.51B | 0.52B | 0.47B | 0.50B | 0.52B | 0.62B | 0.55B | 0.53B | 0.57B | 14.22B | ||||||||||||
| Operating IncomeOp. Inc | 1.61B | 1.52B | 1.54B | 2.09B | 1.84B | 1.78B | 1.63B | 1.82B | 1.90B | 1.86B | 1.62B | 1.93B | 1.98B | 1.90B | 1.60B | 2.06B | 1.95B | 1.84B | 1.64B | 87.71B | |||||||||
| EBIT | 1.61B | 1.52B | 1.54B | 2.09B | 1.84B | 1.78B | 1.63B | 1.82B | 1.90B | 1.86B | 1.62B | 1.93B | 1.98B | 1.90B | 1.60B | 2.06B | 1.95B | 1.84B | 1.64B | 87.71B | |||||||||
| Non-operating items | |||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.03B | 0.08B | -0.06B | 0.25B | 0.25B | 0.28B | 0.12B | 0.06B | 0.02B | 0.04B | 0.11B | 0.17B | 0.00B | -0.05B | 0.01B | 0.12B | 0.09B | 4.00B | |||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.07B | 0.06B | -0.21B | 0.04B | -0.03B | 0.00B | 0.00B | 0.00B | 0.01B | -0.00B | -0.00B | 0.04B | 0.06B | 0.06B | 0.03B | 0.20B | 0.17B | -0.02B | 0.07B | ||||||||||
| Non Operating IncomeNon Op. Inc. | -0.21B | -0.29B | -0.28B | -0.12B | -0.05B | 0.01B | -0.02B | -0.04B | -0.07B | -0.11B | 0.06B | 0.08B | 0.19B | 0.04B | -0.11B | -0.03B | 0.01B | ||||||||||||
| Net income details | |||||||||||||||||||||||||||||
| EBT | 0.37B | 0.35B | 0.30B | 1.89B | 1.56B | 1.51B | 1.51B | 1.76B | 1.91B | 1.84B | 1.58B | 1.86B | 1.87B | 1.96B | 1.68B | 2.25B | 2.00B | 1.73B | 1.64B | 48.55B | |||||||||
| Tax ProvisionsTaxes | 1.65B | 1.50B | 7.62B | 0.39B | 0.33B | 0.26B | 0.30B | 0.37B | 0.40B | 0.38B | 0.32B | 0.41B | 0.40B | 0.42B | 0.37B | 0.47B | 0.34B | 0.33B | |||||||||||
| Profit After TaxPAT | -1.29B | -1.15B | -7.31B | 1.49B | 1.23B | 1.25B | 1.21B | 1.40B | 1.51B | 1.47B | 1.26B | 1.45B | 1.47B | 1.54B | 1.31B | 1.77B | 1.65B | 1.40B | 1.64B | 48.55B | |||||||||
| Income from Non-Controlling InterestsInc. Minority | 36.23B | 40.12B | |||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -1.29B | -1.15B | -7.31B | 1.49B | 1.23B | 1.25B | 1.21B | 1.40B | 1.51B | 1.47B | 1.26B | 1.45B | 1.47B | 1.54B | 1.31B | 1.77B | 1.65B | 1.40B | 1.64B | 48.55B | |||||||||
| Consolidated Net IncomeConsol Net Inc. | 1.29B | 1.15B | 1.09B | 1.49B | 1.23B | 1.25B | 1.21B | 1.40B | 1.51B | 1.47B | 1.26B | 1.45B | 1.47B | 1.54B | 1.31B | 1.77B | 1.65B | 1.40B | 1.29B | 48.55B | |||||||||
| Income towards Parent CompanyParent Net Inc | 1.29B | 1.15B | 1.09B | 1.49B | 1.23B | 1.25B | 1.21B | 1.40B | 1.51B | 1.47B | 1.26B | 1.45B | 1.47B | 1.54B | 1.31B | 1.77B | 1.65B | 1.40B | 1.29B | 48.55B | |||||||||
| Net Income towards Common StockholdersNet Income | 1.29B | 1.15B | 1.09B | 1.49B | 1.23B | 1.25B | 1.21B | 1.40B | 1.51B | 1.47B | 1.26B | 1.45B | 1.47B | 1.54B | 1.31B | 1.77B | 1.65B | 1.40B | 1.29B | 48.55B | |||||||||
| Additional items | |||||||||||||||||||||||||||||
| EPS (Basic) | 10.22 | ||||||||||||||||||||||||||||
| EPS (Diluted) | 10.21 | ||||||||||||||||||||||||||||
| Shares Outstanding | 4.75B | ||||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 4.76B | ||||||||||||||||||||||||||||
| EBITDA | 1.73B | 1.73B | 4.97B | 2.19B | 1.94B | 1.88B | 1.91B | 2.00B | 1.97B | 2.03B | 2.10B | 2.02B | 1.75B | 2.18B | 2.07B | 1.96B | 1.89B | ||||||||||||
| Interest ExpensesInt Expense | 0.03B | 0.08B | -0.06B | 0.25B | 0.25B | 0.28B | 0.12B | 0.06B | 0.02B | 0.04B | 0.11B | 0.17B | 0.00B | -0.05B | 0.01B | 0.12B | 0.09B | 4.00B | |||||||||||
| Tax Rate | 451.37 | 431.32 | 0.00B | 20.89 | 20.94 | 17.23 | 19.92 | 20.91 | 20.89 | 20.33 | 20.46 | 21.91 | 21.31 | 21.61 | 21.88 | 21.01 | 17.18 | 18.83 |
Pull Novo Nordisk A S's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NVO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NVO", "statement": "IS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NVO&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();